Correction: Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation
Year: 2025
Type: erratum
Abstract: Correction on: Wen A, Feng X, Li Y, Cui X, Zou Q, Cai Y, Jin J and He Y (2025) Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation. Front. Immunol. 16:1711451. doi: 10.3389/fimmu.2025.1711451 Error in figure/table The original version of this article has been updated.There was a mistake in the caption of figure 6 as published. During the revision of the manuscript, we supplemented co-immunoprecipitation assays to confirm the physical interaction between MSL1 and MOF. We transfected a Flag-MOF-tagged plasmid into 293T cells; however, during figure preparation, we mistakenly labeled Lane 5 in Figure 6E as "Flag-MOFK274A", which should be corrected to "Flag-MOF". Following the coimmunoprecipitation assays, we used antibodies against the Flag tag and CD274, respectively. In the Western blot annotation in Figure 6E, we erroneously wrote "IB:GAPDH", which should be changed to "IB:CD274". This correction can be verified by the marker positions in the original Western blot images provided in our supplementary materials. The corrected caption of figure 6 appears below.There was a mistake in the caption of figure 5
Source: Frontiers in Immunology
Authors: Aiping Wen, Xuanfei Feng, Yingying Li, Xueli Cui, Qixian Zou, Yong Cai, Jingji Jin, Yunxiao He
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4417497009
Cites:
Cited by:
Related to: